Choreito, a Kampo medicine attenuates detrusor overactivity and bladder pain symptoms in rat tranilast‐induced interstitial cystitis/bladder pain syndrome‐like model
- 15 November 2022
- journal article
- research article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 42 (1) , 56-64
Abstract
Aims: Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic inflammatory condition of the bladder. However, there are only a few medicines that are of pharmaceutical grade and reliably effective for IC/BPS symptoms. Choreito (CRT) is a pharmaceutical‐grade Kampo medicine and has been widely prescribed for patients of lower urinary tract symptoms (LUTS) and BPS in Japan. In this study, we exploratory investigated the effects of CRT on the IC/BPS‐like symptoms induced by tranilast.Methods: The rat IC/BPS‐like model was induced by feeding administration with 0.4% tranilast. The rats were divided into the three following treatment groups: normal diet (Normal), tranilast treatment (Control), and the groups of 1% CRT (CRT) treatment for IC/BPS‐like model. After 4 weeks, continuous cystmetry, locomotor, and vascular permeability was assessed. Furthermore, the cytokine levels in bladder were analyzed by the Bio‐Plex suspension array system and plasma monoamine were measured.Results: Control group exhibited 14.3% decrease of locomotor activity in the dark period, and which were 20.3% increase by 1%CRT treatment. The voiding interval was shorter in control than in other groups. 1%CRT suppressed the shortening of voiding interval. Evans blue leakage of bladder wall observed 44.8% higher in control group than in the normal group. The leakage of 1%CRT group was 33.3% less than in the control group. The cytokine level of IFNγ and VEGF were elevated in the control, and CRT treatment suppressed the elevation of IFNγ in the bladder. Plasma noradrenaline was significantly reduced by CRT treatment compared normal group.Conclusion: These results suggest that CRT can be an effective therapeutic agent for the treatment of IC/BPS‐like symptoms.Keywords
This publication has 22 references indexed in Scilit:
- Uroplakin Peptide-Specific Autoimmunity Initiates Interstitial Cystitis/Painful Bladder Syndrome in MicePLOS ONE, 2013
- Effect of Kampo extracts on urinary stone formation: An experimental investigationInternational Journal of Urology, 2013
- Choreito, a formula from Japanese traditional medicine (Kampo medicine), for massive hemorrhagic cystitis and clot retention in a pediatric patient with refractory acute lymphoblastic leukemiaPhytomedicine, 2012
- Nocturia in Interstitial Cystitis/Painful Bladder SyndromeUrology, 2011
- Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patientsAmerican Journal of Physiology-Renal Physiology, 2008
- Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy: Efficacy in Japanese male patients with ureteral stoneInternational Journal of Urology, 2008
- Interferon γ: a crucial role in the function of induced regulatory T cells in vivoTrends in Immunology, 2006
- Treatment of interstitial cystitisUrology, 2004
- HOW DO PATIENTS WITH INTERSTITIAL CYSTITIS PRESENT?Journal of Urology, 2001
- Neural Control of the Lower Urinary TractInternational Journal of Urology, 1997